Days after Britain’s medicines regulator has advised people with a history of significant allergies not to get the Pfizer-BioNTech COVID-19 vaccine after multiple cases of severe allergies in health workers, US reported cases in the same line which raised tensions.
According to the reports, multiple cases of health workers suffering from serious allergic reaction minutes after getting Pfizer Inc and BioNTech’s coronavirus vaccine were reported. However, Lindy Jones, the director of the emergency department in the capital Juneau where one of the patients was treated stated that the situations are under control.
Assuring that the patients are stable and are recovering, Jones said the symptoms in the middle-aged patient resolved after being administered with allergy treatment epinephrine. To be precise, Anaphylaxis is an overreaction of the body’s immune system, which the UK National Health Service describes as severe and sometimes life-threatening.
However, Pfizer’s CEO Albert Bourla not receiving his own company’s vaccine yet has raised suspicion. In contrary to various allegations levelled on him, Bourla stated that neither he nor other company executives will be vaccinated given limited doses available.
“The health authorities are prioritising the most vulnerable groups and healthcare workers fighting the pandemic from the frontline for the vaccine. It would be unfair if he were to cut the queue and get the vaccine first,” he added.
However, the fact that Bourla is not choosing to get vaccinated first has raised eyebrows. He was accused that the CEO is well aware of the adverse side effects and is waiting for the vaccine to finish the complete trail procedure.
